PubMed Central (PMC) Search Page
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2013 | 44 |
| 2014 | 78 |
| 2015 | 80 |
| 2016 | 64 |
| 2017 | 59 |
| 2018 | 65 |
| 2019 | 92 |
| 2020 | 57 |
| 2021 | 58 |
| 2022 | 65 |
| 2023 | 70 |
| 2024 | 69 |
| 2025 | 73 |
| 2026 | 70 |
-
Publication date
-
-
Publication stage
These filters represent the three primary types of content included in the PMC archive: 1) content published in a scholarly journal 2) peer-reviewed author manuscripts accepted for publication in a journal and 3) preprint versions of articles collected through the NIH Preprint Pilot, made public prior to peer review
-
-
Collections
The PMC Open Access Subset includes journal articles and preprints that are made available under license terms that allow reuse. Historical back issues refers to digitized content from print journals made available in PMC through the Biomedical Journal Digitization Projects.
-
"Cancer Immunol Res"[Journal]
The embargo is the time during which the publisher retains exclusive rights to distribute articles. Those articles are made freely available on the PMC website after the embargo period has ended. Citations for articles under an embargo period will still display in the PMC results list by default. Choose “Exclude” to prevent embargoed articles from displaying in your results.
-
IFNγ-dependent tumor-cell MHC-II is restrained by MAPK signaling and associated with immunotherapy responsiveness in pancreatic ductal adenocarcinoma.
- Chen C, Zhang Y, Li X, Ozmen TY, Ozmen F, Sivagnanam S, Gribbin KP, Blise KE, Yang X, Kim G, Dai RS, Keith D, Sherman MH, Dai MS, Coussens LM, Lopez CD, Sears RC, Mills GB, Byrne KT, Xia Z.
- Cancer Immunol Res. Author manuscript. 2026 Sep 24:10.1158/2326-6066.CIR-25-1612. doi: 10.1158/2326-6066.CIR-25-1612. Online ahead of print.
- PMCID: PMC13682913
Chen C, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13682913 -
ULK1-dependent autophagy initiation promotes MHC-I degradation and immune evasion in HPV-positive head and neck cancer.
- Vu L, Giacobbi NS, Khalil MI, Yang C, Eckerman WJ, Gomez Recinos ED, Garber JD, Bennett AZ, Adams B, Son H, Chahal P, Villa DM, Srivastava T, Martin KR, Welbon CC, Williamson CS, Spanos WC, MacKeigan JP, Olive AJ, Pyeon D.
- Cancer Immunol Res. Author manuscript. 2026 Sep 28:10.1158/2326-6066.CIR-26-0421. doi: 10.1158/2326-6066.CIR-26-0421. Online ahead of print.
- PMCID: PMC13676309
Vu L, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13676309 -
Unveiling Cellular Identities and Gene Expression Pathways in Overlapping Myocarditis and Myositis.
- Fankhauser RG, Johnson DB, Moslehi JJ, Balko JM.
- Cancer Immunol Res. Author manuscript. 2024 Aug 1;12(8):954-955. doi: 10.1158/2326-6066.CIR-24-0506.
- PMCID: PMC13674491
Fankhauser RG, et al.Cancer Immunol Res. Author manuscript. 2024.PMCID: PMC13674491 -
Phenotypic and functional characterization of tumor-reactive T cells in malignant pleural effusions.
- Gaiger NS, Coburn J, Lee MN, Zhang L, Chen HL, Woodard GA, Kluger HM, Schoenfeld DA, Lu BY.
- Cancer Immunol Res. Author manuscript. 2026 Sep 11:10.1158/2326-6066.CIR-26-0293. doi: 10.1158/2326-6066.CIR-26-0293. Online ahead of print.
- PMCID: PMC13659691
Gaiger NS, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13659691 -
IL-21 boosts T cell-therapy efficacy for solid tumors by enhancing mitochondrial Ca2+-mediated motility of effector CD8+ T cells.
- Hoen Rauhut M, Abdullahi F, Walters J, Patel HN, Stich D, Marié IJ, Wen H, Levy DE, Jacot JG, Jacobelli J, Valenca-Pereira F, Rincon M.
- Cancer Immunol Res. Author manuscript. 2026 Sep 21:10.1158/2326-6066.CIR-26-0401. doi: 10.1158/2326-6066.CIR-26-0401. Online ahead of print.
- PMCID: PMC13656791
Hoen Rauhut M, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13656791 -
In Situ Vaccination, Low-Dose Targeted Radionuclide Therapy, and Immune Checkpoint Inhibition Eradicate Poorly Immunogenic Metastatic Tumors in Murine Cancer Models.
- Debnath T, Jin WJ, Patel RB, Carlson PM, Rahman MM, Berg TJ, Kerr CP, Schwartz RW, Wang Y, Hyun M, Ong IM, Weichert JP, Hernandez R, Sondel PM, Morris ZS.
- Cancer Immunol Res. Author manuscript. 2026 Sep 2;14(9):1416-1432. doi: 10.1158/2326-6066.CIR-25-1475.
- PMCID: PMC13644649
Debnath T, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13644649 -
In Vitro Inhibition of STAT5 Signaling Limits CD8+ T-cell Exhaustion and Improves Outcomes in Adoptive T-cell Therapy.
- Shourian M, Bourdin B, El-Hachem N, Ruisseaux C, Vallée A, Ballestero Vidal A, Gingras O, Roméro H, Kwarteng EO, Haddad É, Lavallée VP, Beltra JC, Decaluwe H.
- Cancer Immunol Res. 2026 Oct 5;14(10):1587-1603. doi: 10.1158/2326-6066.CIR-25-1493.
- PMCID: PMC13635738
Shourian M, et al.Cancer Immunol Res. 2026.PMCID: PMC13635738 -
Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma.
- Ma Y, Shi M, Ma M, Li S, Cui N, Li Y, Dang T, Yang R, Bai Y, Wang B, Zhang C, Liu C, Zhang Y.
- Cancer Immunol Res. 2026 Oct 5;14(10):1635-1652. doi: 10.1158/2326-6066.CIR-25-1617.
- PMCID: PMC13635741
Ma Y, et al.Cancer Immunol Res. 2026.PMCID: PMC13635741 -
BET Inhibition Synergizes with RLR Signaling to Enhance Tumor Immunogenicity and T-cell Recognition.
- Baldran-Groves L, Žiberna R, Gerault MA, Cruz De Los Santos M, Kiessling A, Pasca S, Khoshdoozmasouleh N, Post A, Lundqvist A, Wickström S, Kiessling R, Melief J.
- Cancer Immunol Res. 2026 Oct 5;14(10):1670-1684. doi: 10.1158/2326-6066.CIR-25-0777.
- PMCID: PMC13635740
Baldran-Groves L, et al.Cancer Immunol Res. 2026.PMCID: PMC13635740 -
MERTK inhibition cooperates with immunomodulatory cyclophosphamide to induce CXCL9⁺ monocyte-macrophage programming and durable antitumor immunity in triple negative breast cancer.
- Smith AJ, Schrank Z, Guan N, Pedroza DA, Calderon SJ, Yuan X, Zhao N, Gabriel Z, Gao Y, Rivas CH, Liu F, Serody JS, Perou CM, Earp HS, Rosen JM.
- Cancer Immunol Res. Author manuscript. 2026 Aug 17:10.1158/2326-6066.CIR-26-0278. doi: 10.1158/2326-6066.CIR-26-0278. Online ahead of print.
- PMCID: PMC13584615
Smith AJ, et al.Cancer Immunol Res. Author manuscript. 2026.PMCID: PMC13584615